img
img
Vineeta Agarwala
Bio + Health

Vineeta Agarwala

MD, PhD

Investing

More About Vineeta

Vineeta Agarwala, MD, PhD is a General Partner at Andreessen Horowitz (a16z) where she leads investments for the firm’s bio + health fund across biotech, life sciences software, and digital health, with a focus on companies leveraging unique technologies and datasets to advance drug development, personalized medicine, and innovation in patient care delivery.

Prior to joining a16z, Vineeta held many different roles in the healthcare space: as a physician taking care of patients; as an operator at healthtech startups; and as a venture investor on the GV (Google Ventures) life sciences team. She has been a data scientist; a management consultant for biotech, pharmaceutical, and medical device clients at McKinsey & Co; and a Director of Product Management at Flatiron Health (acquired by Roche), where she led the company’s partnership with Foundation Medicine to integrate real-world clinical and genomic data into national-scale data products to accelerate research and development in oncology. She has conducted academic research at Cold Spring Harbor Laboratory, Lawrence Livermore National Laboratory, and the Broad Institute, where she did graduate work in computational biology and human genetics.

Vineeta holds a B.S. in biophysics from Stanford University, and MD and PhD degrees from Harvard Medical School / MIT. She completed her clinical residency at Stanford, and is board certified in internal medicine. Vineeta continues to see patients at Stanford as an adjunct clinical professor in the Division of Primary Care and Population Health.

Vineeta serves on several portfolio company boards, including Amber Bio, BigHat Biosciences, Gate Bio, GC Therapeutics, knownwell, Memora Health, Orbital Therapeutics, Pearl Health, Pomelo Care, Rezo Therapeutics, Thyme Care, and Waymark.

Latest Content

  • Investing in knownwellNew
    Vineeta Agarwala

    This medical home is exactly what knownwell is building – and scaling. Through a hybrid virtual and in-person care model, knownwell offers both primary care as well as longitudinal specialty care, inclusive of weight management, diabetes care, medication (and side effect) management, multi-disciplinary nutritional counseling, and behavioral health services.

  • The Science and Supply of GLP-1s with Brooke Boyarsky Pratt
    Vineeta Agarwala, Brooke Boyarsky Pratt, Kris Tatiossian, and Olivia Webb

    Brooke Boyarsky Pratt, founder and CEO of knownwell, joins Vineeta Agarwala, general partner at a16z Bio + Health.

  • Investing in Valar Labs
    Vineeta Agarwala

    There is perhaps nowhere more exciting or impactful to build such tools than in healthcare—where progress is often so constrained by human expertise. Valar Labs is taking on exactly this challenge, and bringing AI into the toolbox for better cancer care.

  • Intersection of Biotech x High Tech with Vineeta Agarwala
    Vineeta Agarwala, Luke Timmerman, Kris Tatiossian, and Olivia Webb

    Vineeta Agarwala, MD, PhD, joins Luke Timmerman's The Long Run podcast on stage at the Life Science Innovation Northwest Conference.

  • Dark Genome Hunting with Rosana Kapeller and Marty Taylor
    Vineeta Agarwala, Bryan Faust, Rosana Kapeller, Marty Taylor, Kris Tatiossian, and Olivia Webb

    Rosana Kapeller, CEO of Rome Therapeutics, and Marty Taylor, physician-scientist at Harvard Medical School, join Vineeta Agarwala, general partner, and Bryan Faust, investment partner at a16z Bio + Health.

Select Investments

Any investments or portfolio companies mentioned, referred to, or described on this page are not representative of all investments. A list of investments made by funds managed by a16z is available here: https://a16z.com/investment-list/.

go to top